TGA – Consultations on adoption of European Union guidelines in Australia
13 January 2020 Your comments on the proposed adoption or non-adoption of these EU guidelines, particularly your advice on whether you support the proposed action, would be appreciated. Comments may be sent by email or mail and should…
Vaccinations shown to reduce flu mortality rates
9 January 2020 An Australian study has found an association between influenza vaccination and lowered mortality rates from the disease. An Australian study has confirmed flu vaccination effectively reduces mortality from the disease – positive news after a…
Researchers decipher a new way that immune cells detect infections and cancers
10 January 2020 MEDIA RELEASE Melbourne researchers have determined the molecular basis for how an important component of the immune system, called gamma-delta T cells, detects infections and cancers. Published today in Science, the research team from the Peter…
Human immune cells produced in a dish in world first
9 January 2020 A Melbourne research team has reproduced and visualised the earliest developmental steps in human immune cell production in the laboratory and are now set to advance our understanding of childhood diseases like leukemia and autoimmune…
Commencement of commercial-scale GMP extraction of medicinal cannabis resin
7 January 2020 Cann Group Limited (ASX: CAN) and IDT Australia Limited (ASX: IDT) have jointly announced that GMP extraction activities are underway for the first batches of medicinal cannabis resin. The extracted resin will be used as…
Potential risks when dating documents this year
10 January 2020 There has been talk in the media about the potential risks arising from the form of the new year: ‘2020’. The risk is that formatting the date as DD/MM/YY leaves the year column able to…
Five reasons we’re looking forward to the new decade
11 December 2019 By Anthony Farina, Chief Communications Officer and Vice President of Corporate Affairs Whether you call it the “twenty-tens” or the “teens,” the second decade of the 21st Century is drawing to a close. We’re saying farewell…
Opthea Completes Recruitment in Phase 2a Clinical Trial of OPT-302 for Diabetic Macular Edema
7 January 2020 Melbourne, Australia – Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, has completed patient recruitment into the Company’s Phase 2a trial evaluating the safety and efficacy of…
$8.9 million investment for cancer research
18 December 2019 A media release from Senator the Hon. Anne Ruston MP, Acting Minister for Health, about $8.9 million for cancer research in Australia, through Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme. … The Morrison Government has…
Medical Research Future Fund boost to take satellite technology from space to the eye clinic
12 December 2019 The developers of a simple eye test to detect signs of Alzheimer’s disease have won funding to help take their technology from the lab to the eye clinic. Enlighten Imaging, an Australian start-up company incubated…
Watermark to integrate into Griffith Hack
27 November 2019 By Watermark We are pleased to announce that our firm will be integrating into Australian IP firm Griffith Hack in April 2020, and from that time we will operate as one combined firm under the…
Scientists fear insect populations are shrinking. Here are six ways to help
5 December 2019 By David Yeates, CSIRO, Katja Hogendoorn, University of Adelaide, Manu Saunders, University of New England 5 minute read Are you planning a big garden clean-up this summer, or stocking up on fly spray to keep bugs…
